Global Digital Pathology Market is expected to reach USD 692.5 million by 2022. Increasing automation in the field of in vitro diagnostics especially pertaining to pathology is expected to drive the growth of the digital pathology market over the forecast period. Growing prevalence of chronic diseases such as cancer is further expected to heighten the demand for faster and accurate diagnostic tools. Growth in the penetration rates of EHR in the North American and European regions is also likely to have a positive impact on market growth over the forecast period. Inherent advantages associated with digital pathology systems are expected to boost usage rates. Consumers are expected to initiate the use of digital pathology systems in an attempt to curb costs, render improved patient care, improve workflow system and minimize human error related incidences.
Whole slide imaging is expected to grow at a lucrative rate. The technology renders high resolution digital images with multiple magnifications in a shorter period of time and this is expected to promote usage rates over the forecast period.
Browse Full Research Report With TOC On "Digital Pathology Market Size, Report, 2022" at: http://www.radiantinsights.com/research/digital-pathology-market-analysis-by-technology-whole-slide-imaging-telepathology-static-dynamic-by-application-disease-diagnosis-academics-drug-discovery-amp-development-and-segment-forecasts-to-2022
Further key findings from the study suggest:
- Digital pathology services found the largest application in disease diagnosis in 2014. Increasing prevalence of cancer & other chronic diseases heightening the demand for accurate and faster diagnostic tools and greater applicability are some factors accounting for its large share.
- North America was the most matured regional digital pathology market in 2014 and accounted for over 40.0% of revenue. Presence of sophisticated healthcare infrastructure favoring the implementation of electronic medical records and growing demand for device automation is some factors responsible for its large share.
- Asia Pacific region on account of the presence of large untapped opportunities, rapidly improving healthcare infrastructure and increasing usage of digital pathology in academics and research is expected to provide this market with lucrative future growth opportunities.
- Some key players of digital pathology services include GE Healthcare, 3DHistech Inc., Leica Biosystems, Ventana Medical Systems, Inc., Philips Healthcare, Definiens, Olympus Corporation, Omynx LLC, Objective Pathology Services, LigoLAb LLC, Hamamatsu Photonics Inc., and MicroSkan Technologies.
- Providing technologically advanced pathological systems & services and capitalizing on the untapped opportunities via strategic collaborations are some key strategic moves adopted by these market players.
Browse All Reports of This Category at: www.radiantinsights.com/catalog/medical-devices
Global Digital Pathology Technology Outlook (Revenue, USD Million, 2012 - 2022)
- Whole slide Imaging
- Telepathology
- Static
- Dynamic
Global Digital Pathology Application Outlook (Revenue, USD Million, 2012 - 2022)
- Drug Discovery & Development
- Academic
- Disease Diagnosis
Digital Pathology Regional Outlook (Revenue, USD Billion, 2012 - 2022)
- North America
- S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- China
- Japan
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
Related Reports by Radiant Insights:
- Global Bariatric Surgery Devices Market –
http://www.radiantinsights.com/research/global-bariatric-surgery-devices-market-2014-2018
- Global Pancreatic Cancer Market –
http://www.radiantinsights.com/research/global-pancreatic-cancer-market-2014-2018


Apple Turns 50: From Garage Startup to AI Crossroads
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
First Western Ship Transits Strait of Hormuz Since Iran War Began
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 



